Clinical Trials Browser

Phase 4 × INDUSTRY × lenvatinib × Clear all

NCT03573960 2026-03-06

A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer

Phase 4 Completed

Thyroid Neoplasms

NCT04297254 2023-11-15

A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCC

Phase 4 Completed

Gastrointestinal

Carcinoma, Hepatocellular